Literature DB >> 21399496

Qualitative features of the HIV-specific CD8+ T-cell response associated with immunologic control.

Adam R Hersperger1, Stephen A Migueles, Michael R Betts, Mark Connors.   

Abstract

PURPOSE OF REVIEW: Over the past 2 years, a clearer picture has emerged regarding the properties of HIV-specific CD8+ T cells associated with immunologic control of HIV replication. These properties represent a potential mechanism by which rare patients might control HIV replication in the absence of antiretroviral therapy. This review addresses the background and recent findings that have lead to our current understanding of these mechanism(s). RECENT
FINDINGS: Patients with immunologic control of HIV are not distinguished by targeted specificities, or greater numbers or breadth of their HIV-specific CD8+ T-cell response. For this reason, recent work has focused greater attention on qualitative features of this response. The qualitative features most closely associated with immunologic control of HIV are related to the granule-exocytosis-mediated elimination of HIV-infected CD4 T cells. The ability of HIV-specific CD8+ T cells to increase their contents of proteins known to mediate cytotoxicity, such as granzyme B and perforin, appears to be a critical means by which HIV-specific cytotoxic capacity is regulated.
SUMMARY: Investigation from multiple groups has now focused upon HIV-specific CD8+ T-cell granule-exocytosis-mediated cytotoxicity as a correlate of immunologic control of HIV. In the near future, a more detailed understanding of the qualities associated with immunologic control may provide critical insights regarding the necessary features of a response that should be stimulated by immunotherapies or T-cell-based vaccines.

Entities:  

Mesh:

Year:  2011        PMID: 21399496      PMCID: PMC4309378          DOI: 10.1097/COH.0b013e3283454c39

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  58 in total

1.  CD8+ T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses.

Authors:  Geraldine Arrode; Jennifer S Finke; Henry Zebroski; Frederick P Siegal; Ralph M Steinman
Journal:  Eur J Immunol       Date:  2005-01       Impact factor: 5.532

2.  Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.

Authors:  R A Kaslow; C Rivers; J Tang; T J Bender; P A Goepfert; R El Habib; K Weinhold; M J Mulligan
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 3.  Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection.

Authors:  J Lieberman; P Shankar; N Manjunath; J Andersson
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

4.  Unstimulated primary CD4+ T cells from HIV-1-positive elite suppressors are fully susceptible to HIV-1 entry and productive infection.

Authors:  S Alireza Rabi; Karen A O'Connell; Daria Nikolaeva; Justin R Bailey; Benjamin L Jilek; Lin Shen; Kathleen R Page; Robert F Siliciano; Joel N Blankson
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

5.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

6.  HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition.

Authors:  Toshiyuki Miura; Mark A Brockman; Arne Schneidewind; Michael Lobritz; Florencia Pereyra; Almas Rathod; Brian L Block; Zabrina L Brumme; Chanson J Brumme; Brett Baker; Alissa C Rothchild; Bin Li; Alicja Trocha; Emily Cutrell; Nicole Frahm; Christian Brander; Ildiko Toth; Eric J Arts; Todd M Allen; Bruce D Walker
Journal:  J Virol       Date:  2008-12-30       Impact factor: 5.103

7.  Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic.

Authors:  Dong Zhang; Premlata Shankar; Zhan Xu; Brooke Harnisch; Gang Chen; Christoph Lange; Sandra J Lee; Hernan Valdez; Michael M Lederman; Judy Lieberman
Journal:  Blood       Date:  2002-08-22       Impact factor: 22.113

8.  Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy.

Authors:  Stephen A Migueles; Kristin A Weeks; Eric Nou; Amy M Berkley; Julia E Rood; Christine M Osborne; Claire W Hallahan; Nancy A Cogliano-Shutta; Julia A Metcalf; Mary McLaughlin; Richard Kwan; JoAnn M Mican; Richard T Davey; Mark Connors
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

9.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Authors:  Victor Appay; P Rod Dunbar; Margaret Callan; Paul Klenerman; Geraldine M A Gillespie; Laura Papagno; Graham S Ogg; Abigail King; Franziska Lechner; Celsa A Spina; Susan Little; Diane V Havlir; Douglas D Richman; Norbert Gruener; Gerd Pape; Anele Waters; Philippa Easterbrook; Mariolina Salio; Vincenzo Cerundolo; Andrew J McMichael; Sarah L Rowland-Jones
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

10.  Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study.

Authors:  Cyril Dalmasso; Wassila Carpentier; Laurence Meyer; Christine Rouzioux; Cécile Goujard; Marie-Laure Chaix; Olivier Lambotte; Véronique Avettand-Fenoel; Sigrid Le Clerc; Laure Denis de Senneville; Christiane Deveau; Faroudy Boufassa; Patrice Debré; Jean-François Delfraissy; Philippe Broet; Ioannis Theodorou
Journal:  PLoS One       Date:  2008-12-24       Impact factor: 3.240

View more
  57 in total

1.  Comprehensive analysis of unique cases with extraordinary control over HIV replication.

Authors:  Daniel Mendoza; Sarah A Johnson; Bennett A Peterson; Ven Natarajan; Maria Salgado; Robin L Dewar; Peter D Burbelo; Nicole A Doria-Rose; Erin H Graf; Jamieson H Greenwald; Jessica N Hodge; William L Thompson; Nancy A Cogliano; Cheryl L Chairez; Catherine A Rehm; Sara Jones; Claire W Hallahan; Joseph A Kovacs; Irini Sereti; Omar Sued; Sheila A Peel; Robert J O'Connell; Una O'Doherty; Tae-Wook Chun; Mark Connors; Stephen A Migueles
Journal:  Blood       Date:  2012-04-05       Impact factor: 22.113

2.  Born this way? Understanding the immunological basis of effective HIV control.

Authors:  Mark B Feinberg; Rafi Ahmed
Journal:  Nat Immunol       Date:  2012-06-19       Impact factor: 25.606

3.  Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following simian immunodeficiency virus challenges of vaccinated rhesus monkeys.

Authors:  Kathryn E Stephenson; Hualin Li; Bruce D Walker; Nelson L Michael; Dan H Barouch
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

4.  The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.

Authors:  Zaza M Ndhlovu; Eleni Stampouloglou; Kevin Cesa; Orestes Mavrothalassitis; Donna Marie Alvino; Jonathan Z Li; Shannon Wilton; Daniel Karel; Alicja Piechocka-Trocha; Huabiao Chen; Florencia Pereyra; Bruce D Walker
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

5.  HLA B*5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cells.

Authors:  Daniel Mendoza; Cassandra Royce; Laura E Ruff; David R Ambrozak; Máire F Quigley; Thurston Dang; Vanessa Venturi; David A Price; Daniel C Douek; Stephen A Migueles; Mark Connors
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

6.  Differential Gag-specific polyfunctional T cell maturation patterns in HIV-1 elite controllers.

Authors:  Sara Ferrando-Martínez; Joseph P Casazza; Manuel Leal; Kawthar Machmach; Ma Ángeles Muñoz-Fernández; Pompeyo Viciana; Richard A Koup; Ezequiel Ruiz-Mateos
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

7.  Evolution of an attenuated HIV-1 isolate in an elite suppressor.

Authors:  Maria Salgado; Shiv Gandhi; Robert W Buckheit; Gail V Berkenblit; Joel N Blankson
Journal:  AIDS Res Hum Retroviruses       Date:  2013-11-13       Impact factor: 2.205

8.  Short Communication: HIV Controller T Cells Effectively Inhibit Viral Replication in Alveolar Macrophages.

Authors:  Victoria E Walker-Sperling; Christian A Merlo; Robert W Buckheit; Allison Lambert; Patrick Tarwater; Greg D Kirk; M Bradley Drummond; Joel N Blankson
Journal:  AIDS Res Hum Retroviruses       Date:  2016-08-02       Impact factor: 2.205

9.  Vaccines: His best shot.

Authors:  Corie Lok
Journal:  Nature       Date:  2011-05-26       Impact factor: 49.962

Review 10.  Success and failure of the cellular immune response against HIV-1.

Authors:  Stephen A Migueles; Mark Connors
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.